Patent application number | Description | Published |
20120014999 | Diketopiperazine Microparticles with Defined Specific Surface Areas - Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m | 01-19-2012 |
20120071510 | Method and Composition for Treating Migraines - A method for treating migraines is disclosed. The method utilizes a rapid drug delivery system which prevents deactivation or degradation of the active agent, including small molecules and peptides being administered to a patient in need of treatment. In particular, the drug delivery system is designed for inhalation for delivery of drugs to the pulmonary circulation in a rapid and therapeutically effective manner. | 03-22-2012 |
20120164186 | Diketopiperazine Microparticles with Defined Specific Surface Areas - Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m | 06-28-2012 |
20120252728 | Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome - A method of treating functional dyspepsia and/or irritable bowel syndrome in mammals in need of treatment is disclosed herein. The method comprises administering to the mammal a formulation by inhalation, wherein the formulation avoids first pass metabolism of the active ingredient. The method comprises administering a formulation by pulmonary inhalation comprising a diketopiperazine and a glucagon-like peptide (GLP-1), analog, ROSE-010. | 10-04-2012 |
20140045745 | DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED SPECIFIC SURFACE AREAS - Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m | 02-13-2014 |
20140187490 | Val (8) GLP-1 Composition and Method for Treating Functional Dyspepsia and/or Irritable Bowel Syndrome - A method of treating functional dyspepsia and/or irritable bowel syndrome in mammals in need of treatment is disclosed herein. The method comprises administering to the mammal a formulation by inhalation, wherein the formulation avoids first pass metabolism of the active ingredient. The method comprises administering a formulation by pulmonary inhalation comprising a diketopiperazine and a glucagon-like peptide (GLP-1), analog, ROSE-010. | 07-03-2014 |
20140199398 | HIGH CAPACITY DIEKTOPIPERAZINE MICROPARTICLES AND METHODS - Disclosed herein are diketopiperazine microparticles having high capacity for adsorbing a drug or active agent. In particular, the diketopiperazine microparticle are formed using fumaryl diketopiperazine and can comprise a drug in large doses for the treatment of disease or disorders by pulmonary delivery via oral inhalation. | 07-17-2014 |
20140271888 | DIKETOPIPERAZINE MICROPARTICLES WITH DEFINED SPECIFIC SURFACE AREAS - Disclosed herein are diketopiperazine microparticles having a specific surface area of less than about 67 m | 09-18-2014 |
20140302151 | METHODS AND COMPOSITIONS FOR TREATING PAIN - Methods and compositions for treating pain are disclosed. The compositions are based on dry powders comprising microparticles of diketopiperazines and an analgesic active agent. The analgesic in the compositions comprises one or more peptide analgesics or derivatives thereof, which are administered to a subject using a pulmonary inhalation drug delivery system comprising a dry powder inhaler and the analgesic composition. The present compositions produce fewer side effects associated with current opioid therapy. | 10-09-2014 |
20140315953 | METHOD AND COMPOSITION FOR TREATING MIGRAINES - A method for treating migraines is disclosed. The method utilizes a rapid drug delivery system which prevents deactivation or degradation of the active agent, including small molecules and peptides being administered to a patient in need of treatment. In particular, the drug delivery system is designed for inhalation for delivery of drugs to the pulmonary circulation in a rapid and therapeutically effective manner. | 10-23-2014 |